FIT screening

Dikkedarmkanker, ook wel colorectaal carcinoom, is een veelvoorkomende ziekte onder voornamelijk ouderen. Het detecteren van dikke darmkanker in een vroeg stadium kan de overlevingskans van een patiënt aanzienlijk vergroten. Door gebruik te maken van een fecale immunochemische test (FIT) worden kleine hoeveelheden bloed (met behulp van antilichamen voor humaan hemoglobine) opgespoord in ontlastingsmonsters.


Sysmex biedt FIT-tests aan voor twee hoofdgroepen: grootschalig tests voor nationale of regionale bevolkingsonderzoeken, en symptomatische tests die hoofdzakelijk plaatsvinden in ziekenhuizen of klinische omgevingen. Lees hier meer over op onze FIT screening microsite http://www.fitscreening.eu/

  • Magnetic SLN localisation
    Magnetic SLN localisation

Sentimag - Magnetic sentinel lymph node localisation

Most treatments for early breast cancer involve ‘sentinel lymph node biopsy’, or SLNB. This method, which identifies the lymph nodes with the highest potential for harbouring metastases, lets clinicians determine the stage of the cancer and make informed decisions for post-operative care.

Standard SLNB uses radioisotopes. Instead, we offer an effective clinical solution that uses safe magnetic fields to power our diagnostics. This eliminates the concerns related to the safety, workflow and availability associated with ionising radiation. Our system consists of the Sentimag® probe and the Sienna+® magnetic tracer. The tracer is injected into the interstitial tissue to provide a traceable signal. Using the Sentimag® probe, surgeons then locate the sentinel lymph nodes – vital for determining how far the cancer has spread.

Surgeons retain full control, can improve their workflow and provide better patient comfort as they can inject Sienna+® and locate the lymph node without the need for nuclear medicine or special licensing. The Sentimag® and Sienna+® system is an effective and valuable alternative that can be offered in the widest range of hospitals and clinics.

 

A new state-of-the-art approach

• Best practice SLNB can be performed anywhere, by any trained practitioner
• Issues with radioactive materials are eliminated, but with equivalent clinical outcomes
• Surgeon alone is in full control of the SLNB procedure
• Ultrasensitive detection and intuitive localisation of sentinel lymph nodes
• Sienna+® tracer is safe and has a long shelf life
• Sentimag® and Sienna+® are a CE-approved system for SLN localisation

Clinical Results

Magnetic SLNB procedure

Solution for detection of lymph node metastases

Oncology Overview

Go back to the overview of Oncology

Click Here
Watch the Podcast
Watch the video
Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Beelden
  • Video's